Lancet neurology
The most recent articles from:
Lancet Neurol
-
Randomized Controlled Trial
Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study.
Many patients with Parkinson's disease have potentially disabling off episodes that are not predictably responsive to levodopa. In this study, we assessed the safety and efficacy of apomorphine sublingual film as an on-demand therapy for off episodes in patients with Parkinson's disease. ⋯ Cynapsus Therapeutics and Sunovion.